Your browser doesn't support javascript.
loading
Safety and Efficacy of Dupilumab for the Treatment of Hospitalized Patients with Moderate to Severe COVID 19: A Phase IIa Trial.
Sasson, Jennifer; Donlan, Alexandra N; Ma, Jennie Z; Haughey, Heather M; Coleman, Rachael; Nayak, Uma; Mathers, Amy J; Laverdure, Sylvain; Dewar, Robin; Jackson, Patrick E H; Heysell, Scott K; Sturek, Jeffrey M; Petri, William A.
Afiliação
  • Sasson J; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, VA, USA.
  • Donlan AN; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, VA, USA.
  • Ma JZ; Department of Microbiology, Immunology and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA, USA.
  • Haughey HM; Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
  • Coleman R; Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Virginia Health System, Charlottesville, VA, USA.
  • Nayak U; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, VA, USA.
  • Mathers AJ; Center for Public Health Genomics and Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, VA, USA.
  • Laverdure S; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, VA, USA.
  • Dewar R; Department of Pathology, University of Virginia Health System, Charlottesville, VA, USA.
  • Jackson PEH; Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory, Frederick, MD, USA.
  • Heysell SK; Virus Isolation and Serology Laboratory, Frederick National Laboratory, Frederick, MD, USA.
  • Sturek JM; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, VA, USA.
  • Petri WA; Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, Charlottesville, VA, USA.
medRxiv ; 2022 May 19.
Article em En | MEDLINE | ID: mdl-35411349

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: MedRxiv Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: MedRxiv Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos